20th October 2016
Further High Grade Lithium Intersections Finniss Lithium Project
HIGHLIGHTS
Additional high grade lithium assays have been returned in new results from Core’s maiden drilling program at the Finniss Lithium Project
New assay results from the Finniss Lithium Project include:
o 40m @ 1.66% Li2O from 58m (FRC018) at Grants Prospect, including:
10m @ 2.02% Li2O from 65m
5m @ 2.05% Li2O from 84m
1m @ 3.23% Li2O from 85m
o 31m @ 1.61% from 68m (FRC017) at Grants Prospect, including:
4m @ 2.01% from 83m
o 19m @ 0.68% Li2O (FRC014) at Ahoys Prospect
Previous results from Core’s maiden drilling program at the Finniss Lithium Project include:
o 49m @ 1.78% Li2O from 71m (FRC007) at Grants Prospect
o 34m @ 1.60% Li2O from 71m (FRC003) at BP33 Prospect
These additional significant spodumene intersections together with the previous high grade results from multiple prospects confirm Core’s Finniss Lithium Project as a major new lithium discovery
Results from Core’s maiden drilling program will be used to prioritise the appraisal of more than 10 pegmatite prospects within Core’s Finniss Lithium Project
Current aggressive drilling program at Finniss will continue until the start of the upcoming wet season, expected in late November
Update on initial diamond core drilling at Finniss expected next week
- Forums
- ASX - By Stock
- Price driving milestones
20th October 2016 Further High Grade Lithium Intersections...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 268278 | 0.120 |
40 | 2995146 | 0.115 |
60 | 4820343 | 0.110 |
43 | 4085339 | 0.105 |
85 | 4725746 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 2878347 | 41 |
0.130 | 1714806 | 38 |
0.135 | 1280459 | 21 |
0.140 | 837938 | 9 |
0.145 | 762740 | 16 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online